Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
We examine a pair of recent studies focusing on primary care physicians and what they need to provide better service to patients struggling with their mental health. How can these physicians improve their suicide prevention tools?
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
With depressive symptoms rising after an acute COVID-19 infection, study researchers looked at whether these symptoms are a consequence of stress associated with COVID or, do they reflect more specific sequelae associated with the pathophysiology of the illness.
Patients with OUD treated in EDs at OHSU will have a fast-tracked entry to medication-assisted treatment programs, instead of waiting 6 weeks for an appointment.
